Haemostatic balance in cirrhosis

Area of Science:

• Hepatology and Thrombosis Research
• Hemostasis and Coagulation Science

Background:

• Cirrhosis is paradoxically associated with both bleeding and clotting complications.
• Traditional coagulation tests may not accurately reflect the complex hemostatic balance in cirrhosis.

Purpose of the Study:

• To evaluate the hemostatic balance in cirrhosis by assessing procoagulant and anticoagulant factors.
• To analyze in-vitro thrombin generation in cirrhotic patients compared to healthy individuals.

Main Methods:

• Assessed levels of procoagulant factors (VII, II, V, VIII, XII) and inhibitors (protein C, S, antithrombin).
• Measured endogenous thrombin potential (ETP) with and without protein C activation.
• Calculated ratios of procoagulant to anticoagulant factors and ETP ratios.

Main Results:

• Cirrhotic patients had lower overall procoagulant and anticoagulant factors, except for factor VIII (higher) and protein S (similar).
• Procoagulant to anticoagulant factor ratios were elevated in cirrhotics, particularly Factor VIII/Protein C ratio, increasing with Child Pugh class.
• ETP ratios showed a trend towards higher thrombin generation in patients but did not reach statistical significance.

Conclusions:

• Hemostatic alterations in cirrhosis tend to rebalance the system, favoring a hypercoagulable state.
• Increased procoagulant to anticoagulant factor ratios and normal thrombin generation suggest an increased risk of thromboembolism.
• Further research is needed to clarify the clinical implications of these hemostatic changes in cirrhosis.